20 February 2024

Scrip Citeline Commercial reports VIVEbiotech’s predictions for 2024

At the end of 2023, Scrip Citeline Commercial gave us the opportunity to provide predictions for the year ahead.

Read more

14 February 2024

VIVEbiotech forecasts significant growth in lentiviral vectors and CAR-T therapies for 2024

Pharma Manufacturing asked Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, about her predictions on therapeutic advances for 2024.

Read more

13 February 2024

VIVEbiotech presents at a Gyrolab Technology Seminar

Bárbara Rodríguez-Urretavizcaya, Analytical Development Scientist at VIVEbiotech, will be presenting today at a Gyrolab Technology Seminar.

Read more

9 February 2024

VIVEbiotech participates in an article in Endpoints News about the challenges facing lentiviral vector production

VIVEbiotech participates in an article in Endpoints News about the challenges facing lentiviral vector production.

Read more

23 January 2024

Article resulting from a webinar in collaboration with Xpress Biologics, Polyplus, Sartorius

On November 28th VIVEbiotech participated in a webinar invited by Xpress Biologics, Polyplus, Sartorius.

Read more

23 January 2024

VIVEbiotech featured in an article in the Winter print issue of Drug Discovery World

Towards the end of last year, Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, was asked about her predictions for 2024 by the Drug Discovery World.

Read more

22 January 2024

Successful participation of VIVEbiotech at the Advanced Therapies Week

VIVEbiotech has successfully participated in the Advanced Therapies Week conference in Miami.

Read more

22 December 2023

All the VIVEbiotech team wishes you a Merry Christmas and a wonderful 2024

May the New Year be a wonderful twelve-month smile for all of you.

Read more

20 December 2023

Gurutz Linazasoro elected member of the Board of Directors of AseBio

Gurutz Linazasoro, CEO of VIVEbiotech, was elected as a member of the Board of Directors of AseBio, the Spanish Bioindustry Association, at the Ordinary and...

Read more

19 December 2023

VIVEbiotech contributes to a roundtable article in Pharma´s Almanac

VIVEbiotech has contributed to a winter roundtable article in Pharma's Almanac.

Read more